Data / Form D filings / 3Helix, Inc.
3Helix, Inc.: Form D filings
3Helix, Inc., a biotechnology company in Salt Lake City, UT, filed 2 Form D notices with the SEC between 2023 and 2026. The latest, on September 21, 2026, reports $7.8 million sold of a $10 million offering to 13 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 650 Komas, Suite 202, Salt Lake City, UT, 84108
- Phone
- (778) 858-1952
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2001622
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | New notice | $10,000,000 | $7,835,028 | $2,164,972 | 13 | Aug 31, 2026 | sec.gov |
| Nov 29, 2023 | New notice | $6,000,000 | $3,749,987 | $2,250,013 | 8 | Oct 26, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Kirkness | Executive Officer, Director | |
| Nalini D Kelly | Director | |
| Michael Fugman | Director | |
| Noah Nasser | Director | |
| Michael Yu | Director |
Other biotechnology companies in Utah that filed recently
- Life Impact Partners 1 LLC offering · Oct 22, 2026
- Halia Therapeutics, Inc. $3.5 million · Aug 31, 2026
- Paterna BioSciences HoldCo Inc. $6.3 million · Aug 12, 2026
Every Form D from the week of Sep 21, 2026 · All recent filings in Utah · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what 3Helix, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.